Showing results (1021-1030 of 7,009) with videos related to

Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|October 9, 2007
Erlotinib, docetaxel, and gefitinib in sequential cohorts with relapsed non-small cell lung cancerSanjay Popat, Yolanda Barbachano, Sue Ashley, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2007
Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: analysis of 1,145 lymph nodesNael Al-Sarraf, Kathy Gately, Julie Lucey, et al.
Lung Cancer (Amsterdam, Netherlands)|August 2, 2008
MET as a target for treatment of chest tumorsNicole A Cipriani, Oyewale O Abidoye, Everett Vokes, et al.
Lung Cancer (Amsterdam, Netherlands)|August 5, 2008
Induction therapy of loco-regional non-small-cell lung cancer with reliable response and low toxicity (low dose radiotherapy sensitizes tumor to subsequent chemotherapy?)Hiroshi Takita, Kyu H Shin, Andrew Y Soh, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2009
Oral second- and third-line lomustine-etoposide-cyclophosphamide chemotherapy for small cell lung cancerBernard Lebeau, Christos Chouaïd, Mariette Baud, et al.
Lung Cancer (Amsterdam, Netherlands)|February 24, 2009
Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in malignant pleural mesothelioma (MPM) cellsS Amatori, F Papalini, R Lazzarini, et al.
Lung Cancer (Amsterdam, Netherlands)|April 14, 2009
Effects of excision repair cross-complementation group 1 (ERCC1) single nucleotide polymorphisms on the prognosis of non-small cell lung cancer patientsTomoyoshi Takenaka, Tokujiro Yano, Chikako Kiyohara, et al.
Lung Cancer (Amsterdam, Netherlands)|April 22, 2009
Malignant pleural mesothelioma: genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targetsOluf Dimitri Røe, Endre Anderssen, Helmut Sandeck, et al.
Lung Cancer (Amsterdam, Netherlands)|May 20, 2009
COX-2 specific inhibitors enhance the cytotoxic effects of pemetrexed in mesothelioma cell linesSara L O'Kane, Gina L Eagle, John Greenman, et al.
Lung Cancer (Amsterdam, Netherlands)|January 23, 2009
Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patientsXinchen Sun, Fan Li, Ning Sun, et al.
Pageof 701